Article
Epigenetic reprogramming of primary pancreatic cancer cells counteracts their in vivo tumourigenicity
15 Jul 2019
Abstract excerpt
Pancreatic ductal adenocarcinoma (PDAC) arises through accumulation of multiple genetic alterations. However, cancer cells also acquire and depend on cancer-specific epigenetic changes. To conclusively demonstrate the crucial relevance of the epigenetic programme for the tumourigenicity of the cancer cells, we used cellular reprogramming technology to reverse these epigenetic changes. We reprogrammed human PDAC...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
